Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 13861 - 13870 of 24215
Identification Number | Trade Name | Benefit Category |
---|---|---|
02332833 | MYLAN-RIVASTIGMINE CAP 6MG | This is not a Standard Benefit. Special Authorization is required. |
02332922 | ATACAND PLUS TAB 32MG/12.5MG | Standard Benefit for Eligible Clients |
02332957 | ATACAND PLUS TAB 32MG/25MG | Standard Benefit for Eligible Clients |
02333015 | APO-OLANZAPINE TAB 20MG | Standard Benefit for Eligible Clients |
02333031 | NU-QUETIAPINE TAB 25MG | Standard Benefit for Eligible Clients |
02333058 | NU-QUETIAPINE TAB 100MG | Standard Benefit for Eligible Clients |
02333066 | NU-QUETIAPINE TAB 200MG | Standard Benefit for Eligible Clients |
02333074 | NU-QUETIAPINE TAB 300MG | Standard Benefit for Eligible Clients |
02333171 | MUSCLE ACHES & BODY PAIN TAB 650MG | Standard Benefit for Eligible Clients |
02333198 | VINCRISTINE SULFATE IV INJ 1MG/ML | Standard Benefit for Eligible Clients |
Displaying 13861 - 13870 of 24215